Comparing remote and face-to-face delivery of eye movement desensitisation and reprocessing (EMDR) therapy for post-traumatic stress disorder in military veterans

Feasibility randomised controlled trial of remotely delivered eye-movement desensitisation and reprocessing (EMDR) versus face-to-face EMDR for post-traumatic stress disorder (PTSD) in military veterans

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN13912752

Enrollment

Registered

2022-09-30

Start date

2022-10-10

Completion date

Unknown

Last updated

2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Combat-related post-traumatic stress disorder (PTSD) Mental and Behavioural Disorders

Interventions

Study design: The study will be an exploratory single-blind randomised parallel group controlled trial with nested process evaluation to assess fidelity, adherence and factors that influence the outco

remote treatment will take place via Attend Anywhere. All recruitment and research interviews will be undertaken remotely. Sample size: A standard power calculation is not appropriate for a Phase II

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Aged 18 years old and over 2. Informed consent 3. Meet DSM5 criteria for combat-related PTSD 4. Access to stable internet access in a private location

Exclusion criteria

Exclusion criteria: 1. Psychosis 2. DSM5 severe major depressive episode 3. Substance dependence 4. Change in psychotropic medication within one month 5. Suicidal intent

Design outcomes

Primary

Measure	Time frame
Diagnosis and severity of PTSD measured using the Clinician-Administered PTSD Scale for DSM-5 (CAPS-5) at baseline, 20 and 40 weeks after randomisation	—

Secondary

Measure	Time frame
1. Presence and severity of PTSD symptoms measured using the PTSD Checklist (PCL) at baseline, 20 and 40 weeks after randomisation 2. Core symptoms of PTSD and complex PTSD measured using the International Trauma Questionnaire (ITQ) at baseline, 20 and 40 weeks after randomisation 3. Impairment in functioning measured using the Work and Social Adjustment Scale (WSAS) at baseline, 20 and 40 weeks after randomisation 4. Severity of depression measured using the Patient Health Questionnaire (PHQ-9) at baseline, 20 and 40 weeks after randomisation 5. Severity of generalised anxiety disorder (GAD) measured using the GAD-7 assessment at baseline, 20 and 40 weeks after randomisation 6. Alcohol harm measured using the Alcohol Use Disorders Test (AUDIT-O) at baseline, 20 and 40 weeks after randomisation 7. Nature, severity, and impact of insomnia measured using the Insomnia Severity Index (ISI) at baseline, 20 and 40 weeks after randomisation 8. Health-related, quality of life measured using the EQ5D-5L at baseline, 20 and 40 weeks after randomisation 9. Digital skills measured using a Digital Ability questionnaire at baseline	—

Measure

Time frame

1. Presence and severity of PTSD symptoms measured using the PTSD Checklist (PCL) at baseline, 20 and 40 weeks after randomisation 2. Core symptoms of PTSD and complex PTSD measured using the International Trauma Questionnaire (ITQ) at baseline, 20 and 40 weeks after randomisation 3. Impairment in functioning measured using the Work and Social Adjustment Scale (WSAS) at baseline, 20 and 40 weeks after randomisation 4. Severity of depression measured using the Patient Health Questionnaire (PHQ-9) at baseline, 20 and 40 weeks after randomisation 5. Severity of generalised anxiety disorder (GAD) measured using the GAD-7 assessment at baseline, 20 and 40 weeks after randomisation 6. Alcohol harm measured using the Alcohol Use Disorders Test (AUDIT-O) at baseline, 20 and 40 weeks after randomisation 7. Nature, severity, and impact of insomnia measured using the Insomnia Severity Index (ISI) at baseline, 20 and 40 weeks after randomisation 8. Health-related, quality of life measured using the EQ5D-5L at baseline, 20 and 40 weeks after randomisation 9. Digital skills measured using a Digital Ability questionnaire at baseline

—

Countries

United Kingdom, Wales

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026